ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
INTER-EWING-1: INTERnational scientific program in clinical research to improve outcomes of newly diagnosed EWING sarcoma
Protocol ID
RG_21-151 (INTER-EWING-1)
Condition/s
Ewing Sarcoma
Diagnosis Stage
Newly Diagnosed
Location
VIC, WA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Birmingham
Trial Status
Open
Sites
Perth Children's Hospital
Peter MacCallum Cancer Centre
Starship Children's Hospital
Christchurch Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
≥2 years
ANZCTR
ACTRN12624000532505
International registry ID's
ISRCTN17938906
Back to Registry
Study Title INTER-EWING-1: INTERnational scientific program in clinical research to improve outcomes of newly diagnosed EWING sarcoma
Protocol ID RG_21-151 (INTER-EWING-1)
Disease (Sub Disease) Ewing Sarcoma
Diagnosis Stage Newly Diagnosed
Location VIC / WA / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham
Links https://www.isrctn.com/ISRCTN17938906
Trial Status Open
Trial Open Date 21/06/2024
Sites Perth Children's Hospital/ Peter MacCallum Cancer Centre/ Starship Children's Hospital / Christchurch Hospital /
Study Type Treatment
Phase Phase 3
Age Eligibility ≥2 years
ANZCTR ACTRN12624000532505
International registry ID's ISRCTN17938906

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168